ClinicalTrials.Veeva

Menu

Dietary Supplementation With Blueberry in OA

U

University of Exeter

Status

Enrolling

Conditions

Knee Osteoarthritis

Treatments

Dietary Supplement: Blueberry powder supplement
Dietary Supplement: Maltodextrin supplementation

Study type

Interventional

Funder types

Other

Identifiers

NCT05784545
IRAS Number: 318841

Details and patient eligibility

About

Osteoarthritis is a painful long term joint condition that is associated with poor quality of life. There are no treatments to prevent it. Inflammation is one cause of osteoarthritis. This inflammation is complex. It involves many joint tissues, like cartilage and fat. It also involves many proteins that act as inflammatory 'signals'. Safely targeting these proteins with medications has so far proved ineffective. Physiotherapy and weight loss can help osteoarthritis, but there is a need for other approaches. Blueberries are rich in natural chemicals called polyphenols; these have well-established anti-inflammatory effects.

Blueberries and other fruits may improve osteoarthritis symptoms, but the investigators do not know how this improvement happens. It may be that these foods reduce inflammation within the joint tissues. They will investigate this. This will help us to understand 1) how blueberries improve osteoarthritis symptoms and 2) whether dietary supplementation with blueberries could slow down joint damage in osteoarthritis, rather than just improving symptoms. Additionally, high levels of joint inflammation predict poorer recovery from joint replacement surgery. Therefore, blueberry supplementation may hasten this recovery. Fifty eight people scheduled to have a knee replacement for osteoarthritis will receive either six weeks blueberry supplementation or a placebo pre-surgery. Participants will continue the supplementation for six weeks after surgery. First, this study will use tissue samples (cartilage, fat and the joint lining called synovium) obtained during surgery to investigate the effects of pre-operative blueberry supplementation on markers of joint inflammation. Second, this study will assess the ability of dietary supplementation with blueberries to improve the symptoms of osteoarthritis. Finally, this study will investigate the effect of blueberry supplementation on recovery from total knee replacement. Our investigations may provide evidence to support dietary supplementation with blueberries to slow down osteoarthritis progression and to improve recovery from osteoarthritis joint replacement surgery.

Enrollment

58 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants capable of giving informed consent
  • Sex: Male and female
  • Age: > 40 years - Those under 40 are more likely to have an undiagnosed secondary cause of osteoarthritis
  • BMI: > 18 kg/m2
  • Listed to have a total knee replacement for osteoarthritis
  • Participants are permitted to participate in other ongoing surgical intervention studies, as long as these are not trials of a dietary supplement or a medication.

Exclusion criteria

  • Those who have received intravenous or oral immunosuppressant medications in past 2 years
  • Those who have had intra-articular steroid injection in 6 months preceding surgery.
  • Some secondary causes of osteoarthritis (mechanistic confounders that are likely to influence tissue inflammation measures:
  • Known congenital joint disorders
  • Other inflammatory arthritis e.g. rheumatoid arthritis
  • Avascular necrosis, infectious arthritis
  • Paget disease
  • Osteopetrosis
  • Osteochondritis dissecans
  • Hemochromatosis
  • Wilson's disease
  • Hemoglobinopathy
  • Ehlers-Danlos syndrome
  • Marfan syndrome
  • Acromegaly
  • Those typically consuming more than eight 80 g portions (or juice equivalent) of blueberries, blackberries, strawberries, raspberries, blackcurrants, pomegranate or cherries per week
  • Those with a known fruit allergy, for which they carry an adrenaline auto-injector or have required anti-histamine, adrenaline, glucocorticoid or beta-agonist treatment.
  • Those who cannot adequately understand verbal explanations or written information given in English

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

58 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Treatment:
Dietary Supplement: Maltodextrin supplementation
Blueberry Supplementation
Experimental group
Treatment:
Dietary Supplement: Blueberry powder supplement

Trial contacts and locations

1

Loading...

Central trial contact

MARY OLEARY; LAUREN STRUSZCZAK

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems